Emerging Science and Therapies in Non-small Cell Lung Cancer: Targeting the MET Pathway

Clinical Lung Cancer

Volumn 15, Issue 6, 2014, Pages 475-

  Kris, Mark G ^a   Arenberg, Douglas A ^b   Herbst, Roy S ^c   Riely, Gregory J ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c YALE CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MET PROTEIN, HUMAN; SCATTER FACTOR RECEPTOR;

ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE BASED MEDICINE; HUMAN; LUNG NEOPLASMS; METABOLISM; MOLECULARLY TARGETED THERAPY; PERSONALIZED MEDICINE; SIGNAL TRANSDUCTION; TRENDS;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

EID: 84931067748     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.08.001     Document Type: Note

References (0)